Antagonism of cannabinoid receptor 2 pathway suppresses IL-6-induced immunoglobulin IgM secretion

Por Feng, Rentian, Milcarek, Christine A, Xie, Xiang-Qun
Publicado em 2014

Mistic and TarCF as fusion protein partners for functional expression of the cannabinoid receptor 2 in Escherichia coli

Por Chowdhury, Ananda, Feng, Rentian, Tong, Qin, Zhang, Yuxun, Xie, Xiang-Qun
Publicado em 2012

Trisubstituted Sulfonamides: A New Chemotype for Development of Potent and Selective CB(2) Receptor Inverse Agonists

Por Ouyang, Qin, Tong, Qin, Feng, Rentian, Myint, Kyaw-Zeyar, Yang, Peng, Xie, Xiang-Qun
Publicado em 2013

Examining the critical roles of human CB2 receptor residues Valine 3.32 (113) and Leucine 5.41 (192) in ligand recognition and downstream signaling activities

Por Alqarni, Mohammed, Myint, Kyaw Zeyar, Tong, Qin, Yang, Peng, Bartlow, Patrick, Wang, Lirong, Feng, Rentian, Xie, Xiang-Qun
Publicado no Biochem Biophys Res Commun (2014)

Targeting Cannabinoid Receptor-2 Pathway by Phenylacetylamide Suppresses the Proliferation of Human Myeloma Cells Through Mitotic Dysregulation and Cytoskeleton Disruption

Por Feng, Rentian, Tong, Qin, Xie, Zhaojun, Cheng, Haizi, Wang, Lirong, Lentzsch, Suzanne, Roodman, G. David, Xie, Xiang-Qun
Publicado no Mol Carcinog (2015)

Novel Triaryl Sulfonamide Derivatives as Selective Cannabinoid Receptor 2 Inverse Agonist and Osteoclast Inhibitor: Discovery, Optimization and Biological Evaluation

Por Yang, Peng, Wang, Liping, Feng, Rentian, Almehizia, Abdulrahman A., Tong, Qin, Myint, Kyaw-Zeyar, Ouyang, Qin, Alqarni, Mohammed Hamed, Wang, Lirong, Xie, Xiang-Qun
Publicado em 2013

Multiple myeloma–derived MMP-13 mediates osteoclast fusogenesis and osteolytic disease

Por Fu, Jing, Li, Shirong, Feng, Rentian, Ma, Huihui, Sabeh, Farideh, Roodman, G. David, Wang, Ji, Robinson, Samuel, Guo, X. Edward, Lund, Thomas, Normolle, Daniel, Mapara, Markus Y., Weiss, Stephen J., Lentzsch, Suzanne
Publicado no J Clin Invest (2016)

Lead Discovery, Chemistry Optimization, and Biological Evaluation Studies of Novel Biamide Derivatives as CB(2) Receptor Inverse Agonists and Osteoclast Inhibitors

Por Yang, Peng, Myint, Kyaw-Zeyar, Tong, Qin, Feng, Rentian, Cao, Haiping, Almehizia, Abdulrahman A., Alqarni, Mohammed Hamed, Wang, Lirong, Bartlow, Patrick, Gao, Yingdai, Gertsch, Jürg, Teramachi, Jumpei, Kurihara, Noriyoshi, Roodman, Garson David, Cheng, Tao, Xie, Xiang-Qun
Publicado em 2012

Blocking the ZZ Domain of Sequestosome1/p62 Suppresses Myeloma Growth and Osteoclast Formation In Vitro and Induces Dramatic Bone Formation in Myeloma-Bearing Bones In Vivo

Por Teramachi, Jumpei, Silbermann, Rebecca, Yang, Peng, Zhao, Wei, Mohammad, Khalid S., Guo, Jianxia, Anderson, Judith L., Zhou, Dan, Feng, Rentian, Myint, Kyaw-Zeyar, Maertz, Nathan, Beumer, Jan H., Eiseman, Julie L., Windle, Jolene J., Xie, Xiang-Qun, Roodman, G. David, Kurihara, Noriyoshi
Publicado no Leukemia (2015)